Lipid remodelling and an altered membrane proteome may drive the effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion

Research output: Contribution to journalArticle

Documents

Links

DOI

  • Stewart Jeromson
  • Ivor Mackenzie
  • Mary K Doherty
  • Phillip D Whitfield
  • Gordon Bell
  • James Dick
  • Andy Shaw
  • Francesco Rao
  • Stephen Ashcroft
  • Andrew Philp
  • Stuart Galloway
  • Iain J. Gallagher
  • D. Lee Hamilton

View graph of relations

Original languageEnglish
Article numberajpendo.00438.2015
JournalAmerican Journal of Physiology - Endocrinology And Metabolism
Early online date27 Jun 2017
DOIs
Publication statusE-pub ahead of print - 27 Jun 2017

Abstract

In striated muscle, EPA and DHA have differential effects on the metabolism of glucose and differential effects on the metabolism of protein. We have shown that, despite similar incorporation, treatment of C2C12 myotubes (CM) with EPA but not DHA improves glucose uptake and protein accretion. We hypothesized that these differential effects of EPA and DHA may be due to divergent shifts in lipidomic profiles leading to altered proteomic profiles. We therefore carried out an assessment on the impact of treating CM with EPA and DHA on lipidomic and proteomic profiles. FAME analysis revealed that both EPA and DHA led to similar but substantial changes in fatty acid profiles. Global lipidomic analysis showed that EPA and DHA induced large alterations in the cellular lipid profiles and in particular, the phospholipid classes. Subsequent targeted analysis confirmed that the most differentially regulated species were phosphatidylcholines and phosphatidylethanolamines containing long chain fatty acids with 5 (EPA treatment) or 6 (DHA treatment) double bonds. As these are typically membrane associated lipid species we hypothesized that these treatments differentially altered the membrane-associated proteome. SILAC based proteomics of the membrane fraction revealed significant divergence in the effects of EPA and DHA on the membrane associated proteome. We conclude that the EPA specific increase in polyunsaturated long chain fatty acids in the phospholipid fraction is associated with an altered membrane associated proteome and these may be critical events in the metabolic remodelling induced by EPA treatment.

Bibliographic note

Copyright © 2017, American Journal of Physiology-Endocrinology and Metabolism

Download statistics

No data available

ID: 2251026